Excited to welcome the Summer 2024 Intern Cohort at Alamar Biosciences! 🌟 We're thrilled to have a group of talented and passionate individuals joining us this summer. Welcome aboard! #AlamarBiosciences #Internship2024 #FutureLeaders #BiotechInnovation

Exciting news! We are joining forces with the Biomarkers of Aging Consortium to revolutionize longevity research! Read the release! ow.ly/vrmF50SqTcw

We are here live at the 2nd Annual Symposium for Human Proteome and Health! Join us at 09:45 for an exclusive look at the next generation of #proteomics technology and learn about the cutting-edge capabilities of #NULISA. Learn more 👉 ow.ly/Wr6t50SqxbW

Join Alamar CTO, Xiao-Jun Ma, during today's Satellite Symposium, for a discussion on Translating Innate and Adaptive Immune Therapies. Tune in at 16:35 to get an exclusive look at the cutting-edge capabilities of #NULISA and the #ARGO HT System. 👉 ow.ly/XxvC50StlXQ

Happy Independence Day! ❤️🤍💙 Today, let's honor the ingenuity and perseverance that define our nation. Together, we can build a healthier and brighter future!

🎙️Join us for the latest episode of Mendelspod as we deep dive into the groundbreaking advancements in #Alzheimer's research with Dr. Henrik Zetterberg, one of the world's leading experts from the University of Gothenburg. New episode out now 👉 ow.ly/FJ6150Sxr08

We're excited to return to #AAIC2024 in Philadelphia, PA! Join us as we showcase our groundbreaking #NULISA and #ARGO HT protein biomarker detection technology for pTau and beyond in the fight against #Alzheimer’s disease. Stay tuned for more updates 👉 ow.ly/IYOX50SBWXj

#AAIC2024 is coming! Don't miss our Product Theater July 30 to hear Amanda Heslegrave, PhD of UCL and Thomas Karikari, PhD of Univ of Pitt, present on our groundbreaking #NULISA and #ARGO HT protein biomarker detection technology for pTau and beyond! 👉ow.ly/w7kn50SEJ99

#AAIC2024 is here! Explore groundbreaking research powered by the #NULISA Platform during several featured presentations & posters and discover how NULISA sets a new standard in protein biomarker analysis with attomolar sensitivity and high multiplexing. 👉ow.ly/4v9Y50SIKyq

#AAIC24 some of the AlamarBio #NULISA emerging data being presented today. Ilaria Pola demonstrating the connection of peripheral immune system and TSPO PET Kübra Tan showing the ability to determine APOE genetic status via a protein assay combined with p-tau217

Protein changes in the blood and CSF beyond p-tau217 in patients with Mild Cognitive impairment. Are they important for disease progression or staging? #AAIC24 AlamarBio Andrea L. Benedet

More #NULISA data looking at plasma changes in #Lewy Body #Dementia (SAA+ and Ab-) compared to AD (without a-syn seeding) AlamarBio Andrea L. Benedet

The collection of #blood #biomarkers studies using NULISA as presented at day two of #AAIC2024 is now available as a pre-print 🩸🧪🧠 medrxiv.org/content/10.110… Andrea L. Benedet Marc Suárez-Calvet 🧠🧪 🩺🌈 @Alamarbio Jonathan Schott Barbara Alessandro Padovani Göteborgs universitet / University of Gothenburg Barcelonaβeta Brain Research Center

Don't miss our Product Theater happening TODAY at 12:25 pm in the Exhibit Hall and experience pTau and beyond, with the #NULISAseq CNS Disease Panel 120 for high sensitivity, multiplexed analysis of CNS disease biomarkers from biofluids. 🧠🔬 See you there 👋

⏰ T-minus 10 minutes until we kick off our Product Theater presentations! Join us in Exhibit Hall to experience pTau and beyond, with the #NULISAseq CNS Disease Panel 120 for high sensitivity, multiplexed analysis of CNS disease biomarkers from biofluids. 🧠🔬

📣 Exciting News 📣 We’re thrilled to announce that Dr. Holden Maecker at Stanford University's Human Immune Monitoring Center is the first #ARGO HT hero to be part of Alamar’s prestigious #ARGOnaut Club! Check out their recent publication here: ow.ly/A7Cj50SQg63

🎓🔬 Back to School with the #ARGO HT System! 🔬🎓 Utilizing the #NULISA platform with ultra-high sensitivity, multiplex analysis, and a fully automated workflow, learn how you can experience this groundbreaking #proteomics technology 🎉👉 ow.ly/TvOc50T75wb

✈️ Kicking off September in Cambridge, UK! Join us next week at the 2024 Meeting of the International Neurotrauma Society (INTS), to learn about the groundbreaking research powered by the #NULISA Platform. See you there! 👋 ow.ly/oABv50TaoBa #INTS2024

🌞 Say Goodbye to Summer with a new era of proteomics! It's the perfect time to elevate your research with the groundbreaking #NULISA Platform! With unparalleled sensitivity & multiplexing capabilities discover the new gold standard in Protein Analysis 👉ow.ly/RrCO50T8i8b

🌟 Happy Labor Day from Alamar Biosciences! 🌟 As we honor the incredible efforts of workers across all industries, let’s take a moment to appreciate the impact of every team member, researcher, and partner in our mission to push the boundaries of science.